Stay updated on Sitagliptin in GVHD: Grade 3-4 Clinical Trial
Sign up to get notified when there's something new on the Sitagliptin in GVHD: Grade 3-4 Clinical Trial page.

Latest updates to the Sitagliptin in GVHD: Grade 3-4 Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.4.2 was added to the history, and the prior site-wide funding/operating status notice (v3.4.1) was removed. These are administrative updates and do not affect trial content or data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

- Check21 days agoChange DetectedNotice added about a government funding lapse and NIH Clinical Center operating status, with a link for details. The page revision changed from v3.4.0 to v3.4.1.SummaryDifference0.9%

- Check28 days agoChange DetectedUI refinements were added to the history view, including a glossary toggle, color-coded change indicators and a revised revision label (v3.4.0), plus a capitalization tweak in the No FEAR Act data label.SummaryDifference1%

- Check42 days agoChange DetectedThe Record History now includes a new revision entry v3.3.4 and removes v3.3.3.SummaryDifference0.1%

- Check63 days agoChange DetectedThe history shows a new Revision: v3.3.3 was added, and HHS Vulnerability Disclosure and Revision: v3.3.2 were removed, indicating site maintenance updates rather than changes to trial data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check85 days agoChange DetectedAdded Revision: v3.3.2 to the record history and removed Revision: v3.3.1.SummaryDifference0.1%

Stay in the know with updates to Sitagliptin in GVHD: Grade 3-4 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sitagliptin in GVHD: Grade 3-4 Clinical Trial page.